Drug Trial Radar · NCT01324128
A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
Last checked: Nov 20, 2026Latest source record: Apr 24, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,059
Actual
Start
Mar 2011
Primary completion
Apr 2012
Study completion Oct 2012
Sponsor
- Lead sponsor
- Vifor PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- Fresenius Medical Care North America
- First posted
- Mar 28, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3, randomised, active controlled, multicentre study to investigate the safety and efficacy of PA21, a phosphate binder, for control of hyperphosphataemia in dialysis patients. The primary objective is to establish the efficacy of PA21 for lowering phosphate levels in these patients.
Conditions
- Chronic Kidney Disease Requiring Chronic Dialysis
Interventions
PA21 (2.5 g tablet containing 500 mg iron)Drug
Dose range of 5.0 g/day (2 tablets/day) to 15.0 g/day (6 tablets/day).
Sevelamer carbonateDrug
Dose range of 2.4 g/day (3 tablets/day) to 14.4 g/day (18 tablets/day)
PA21-1 (1.25 g tablet containing 250 mg iron)Drug
Low dose comparator (1.25 g/day)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Serum Phosphorus Levels From Week 24 to Week 27Time frame: Week 24, Week 27
Locations
15 sites in 15 countries. Site status is shown where the registry gives one.
Site not named
San Antonio, Texas
LKH St. Polten
Sankt Pölten, Austria
CHU Sart Tilman
Liège, Belgium
Clinical Hospital Center Rijeka
Rijeka, Croatia
Dialysis Centre Fresenius Medical Care
Sokolov, Czechia
KfH Nierenzentrum Berlin-Neukoelln
Berlin, Germany
Vidzemes Hospital
Valmiera, Latvia
Vilnius University Hospital Santariskiu Clinics
Vilnius, Lithuania
Teaching Hospital no.1 of Medical University of Lodz
Lodz, Poland
Dialmed Clinic SRL
Sibiu, Romania
City Mariinsky Hospital
Saint Petersburg, Russia
Zvezdara Clinical Medical Center
Belgrade, Serbia
Lakeview Hospital
Benoni, South Africa
Mykolayiv Regional Hospital
Mykolayiv, Ukraine
Dorset County Hospital NHS Foundation Trust
Dorset, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.